RT Book, Section
A1 Hawkins, Douglas S.
A1 Barr, Frederic G.
A2 Rudolph, Colin D.
A2 Rudolph, Abraham M.
A2 Lister, George E.
A2 First, Lewis R.
A2 Gershon, Anne A.
SR Print(0)
ID 7043352
T1 Chapter 455. Rhabdomyosarcoma
T2 Rudolph's Pediatrics, 22e
YR 2011
FD 2011
PB The McGraw-Hill Companies
PP New York, NY
SN 978-0-07-149723-7
LK accesspediatrics.mhmedical.com/content.aspx?aid=7043352
RD 2024/04/24
AB Rhabdomyosarcoma  (RMS)  is  the  most  common  soft  tissue  tumor  in  children,  representing  approximately  5%  of  all  cancers  among  children  and  adolescents.1-5  Approximately  350  new  cases  are  diagnosed  each  year  in  the  United  States,  for  an  annual  incidence  of  4.3  per  million  children  and  adolescents  younger  than  20  years.1  Although  RMS  can  occur  in  adolescents  and  adults,  two  thirds  of  patients  are  less  than  10  years  of  age.1,4  The  incidence  of  RMS  is  slightly  higher  in  males.1  With  current  multimodal  therapy  (including  chemotherapy,  radiotherapy,  and  surgery),  approximately  70%  of  children  with  RMS  can  be  cured.2-6